Certolizumab

Products Certolizumab is commercially available as a solution for injection (Cimzia). It has been approved in many countries since 2007. Structure and properties Certolizumab is the Fab’ fragment of a recombinant humanized antibody. It is conjugated to polyethylene glycol (PEG) and is therefore also known as certolizumab pegol. Effects Certolizumab (ATC L04AB05) has selective immunosuppressive … Certolizumab

Turoctocog Alfa Pegol

Products Turoctocog alfa pegol was approved in the US, EU, and many countries in 2019 as a powder and solvent for solution for injection (Esperoct). Structure and properties Turoctocog alfa pegol is a recombinant and modified human factor VIII (rFVIII) produced by biotechnological methods. A polyethylene glycol (PEG) with a molecular mass of 40 kDa … Turoctocog Alfa Pegol